MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$106,556K
EPS
-$1.76
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
90,300
General and administrative
22,491
Total operating expenses
112,791
Total operating loss
-112,791
Interest income, including amortization and accretion income
6,631
Other income (expense)
77
Total other income
6,708
Loss before income taxes
-106,083
Income tax provision, net
108
Net loss
-106,191
Unrealized loss on marketable securities
-179
Currency translation adjustment
-186
Total other comprehensive loss
-365
Total comprehensive loss
-106,556
Basic EPS
-1.76
Diluted EPS
-1.76
Basic Average Shares
60,337,608
Diluted Average Shares
60,337,608
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$106,556K Net loss-$106,191K Total othercomprehensive loss-$365K Interest income,including amortization...$6,631K Other income(expense)$77K Loss before incometaxes-$106,083K Income tax provision,net$108K Currency translationadjustment-$186K Unrealized loss onmarketable securities-$179K Total other income$6,708K Total operating loss-$112,791K Total operatingexpenses$112,791K Research and development$90,300K General andadministrative$22,491K

Aura Biosciences, Inc. (AURA)

Aura Biosciences, Inc. (AURA)